chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Oral discomfort, Pruritus
Clinical narrative: Patient had no adverse symptoms while at the vaccine clinic. She called the vaccine clinic at 2:38pm and stated after she got back to work her lips "felt funny" . That symptom resolved but then she started itching all over her body. I recommended she consult with the pharmacist in the retail pharmacy where she works ( an afilliate of SBMC) to ask about an over the counter medication that would help with her symptoms given she is on other medication .
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine given on 9/28/21 with expiration date of 9/21/21. Janssen notified/consulted;inquiry#0259438. Dr notified/consulted. Patient notified-suggested antibody testing be done 2 weeks after receiving vaccine.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Disorientation, Headache, Irritability, Lethargy
Clinical narrative: Lethargy, muscle aches, headache, disoriented without memory of incidents, urinary incontinence, agitation, loss of balance. Treated symptoms at home with assistance and reported to pharmacist. By the way, symptoms subsided the next am except for muscle aches.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Urinary incontinence
Clinical narrative: Lethargy, muscle aches, headache, disoriented without memory of incidents, urinary incontinence, agitation, loss of balance. Treated symptoms at home with assistance and reported to pharmacist. By the way, symptoms subsided the next am except for muscle aches.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Feeling abnormal, Headache, Nausea
Clinical narrative: After my second shot on 09/29/2021 I experienced brain fog. The next day I woke up with a sore throat, headache, fatigue, nausea. I experienced these symptoms on 09/30/2021 - 10/01/2021. On 10/02/2021 I still experienced sore throat, headache, fatigue and now a cough. On 10/03/2021 - 10/04/2021 I am still experiencing fatigue, headache, sore throat, cough with green mucus, and throat swollen/ pain with deep breath. I am going to visit the hospital today. I?ve been taking DayQuil which has helped a little.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Painful respiration, Pharyngeal swelling, Secretion discharge
Clinical narrative: After my second shot on 09/29/2021 I experienced brain fog. The next day I woke up with a sore throat, headache, fatigue, nausea. I experienced these symptoms on 09/30/2021 - 10/01/2021. On 10/02/2021 I still experienced sore throat, headache, fatigue and now a cough. On 10/03/2021 - 10/04/2021 I am still experiencing fatigue, headache, sore throat, cough with green mucus, and throat swollen/ pain with deep breath. I am going to visit the hospital today. I?ve been taking DayQuil which has helped a little.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Impaired work ability, Tinnitus
Clinical narrative: Tinnitus developed suddenly two days later along with chills.  Patient is a music teacher, now unable to play piano without kicking up  noise in ears, symptoms persisting ever since.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Cough, Oropharyngeal pain, Respiratory tract congestion, Vaccine breakthrough infection
Clinical narrative: This case met criteria for vaccine breakthrough review. Symptoms include chest congestion, cough, sore throat and back pain.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: patient was 16 and received the moderna vaccine. Patient had no adverse effects reported as of 10/4/2021
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse events or outcome, just that the vaccine was administered after the 30 days of received by our clinic.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine error - Vaccine was administered past its beyond use date. The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Death, Endotracheal intubation
Clinical narrative: 51 yo male pt s/p Pfizer COVID vaccination: dose 1 on 3/4/21 and dose 2 on 3/25/21. PMH of ALL s/p MUD PBSCT 1/15/20 c/b GVHD of the skin and joints for which he is treated with tacrolimus, prednisone, and ruxolitinib at baseline; tacro and rux held on admission. Presented to the ED 8/26 after an assisted fall at home. Of note, he tested positive for COVID on 8/24 at outside institution. He underwent monoclonal antibody infusion and decompensated shortly afterward. Upon arrival to ED, he was found to be hypoxic requiring HHFNC and was admitted to hospital for further care. Received remdesivir and dexamethasone. Hospital course complicated by acute hypoxic respiratory failure in the setting of COVID PNA with superimposed PsA/MSSA/E. Faecalis PNA. Despite prolonged antibiotic treatment and heated high flow oxygen therapy, pt became increasingly tachycardic and acutely decompensated requiring intubation, 3-pressor support, inhaled veletri, proning, and bicarb infusion. His oxygen saturation continued to drop and he was profoundly hypotensive. After discussion with the patient's wife and children, the decision was made to pursue comfort care. Pressor support was decreased and the patient expired shortly after at 10:30AM on 9/17.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Enterococcal infection, Fall, Hypotension, Hypoxia, Intensive care
Clinical narrative: 51 yo male pt s/p Pfizer COVID vaccination: dose 1 on 3/4/21 and dose 2 on 3/25/21. PMH of ALL s/p MUD PBSCT 1/15/20 c/b GVHD of the skin and joints for which he is treated with tacrolimus, prednisone, and ruxolitinib at baseline; tacro and rux held on admission. Presented to the ED 8/26 after an assisted fall at home. Of note, he tested positive for COVID on 8/24 at outside institution. He underwent monoclonal antibody infusion and decompensated shortly afterward. Upon arrival to ED, he was found to be hypoxic requiring HHFNC and was admitted to hospital for further care. Received remdesivir and dexamethasone. Hospital course complicated by acute hypoxic respiratory failure in the setting of COVID PNA with superimposed PsA/MSSA/E. Faecalis PNA. Despite prolonged antibiotic treatment and heated high flow oxygen therapy, pt became increasingly tachycardic and acutely decompensated requiring intubation, 3-pressor support, inhaled veletri, proning, and bicarb infusion. His oxygen saturation continued to drop and he was profoundly hypotensive. After discussion with the patient's wife and children, the decision was made to pursue comfort care. Pressor support was decreased and the patient expired shortly after at 10:30AM on 9/17.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Oxygen saturation decreased, Pneumonia, SARS-CoV-2 test positive, Staphylococcal infection, Tachycardia
Clinical narrative: 51 yo male pt s/p Pfizer COVID vaccination: dose 1 on 3/4/21 and dose 2 on 3/25/21. PMH of ALL s/p MUD PBSCT 1/15/20 c/b GVHD of the skin and joints for which he is treated with tacrolimus, prednisone, and ruxolitinib at baseline; tacro and rux held on admission. Presented to the ED 8/26 after an assisted fall at home. Of note, he tested positive for COVID on 8/24 at outside institution. He underwent monoclonal antibody infusion and decompensated shortly afterward. Upon arrival to ED, he was found to be hypoxic requiring HHFNC and was admitted to hospital for further care. Received remdesivir and dexamethasone. Hospital course complicated by acute hypoxic respiratory failure in the setting of COVID PNA with superimposed PsA/MSSA/E. Faecalis PNA. Despite prolonged antibiotic treatment and heated high flow oxygen therapy, pt became increasingly tachycardic and acutely decompensated requiring intubation, 3-pressor support, inhaled veletri, proning, and bicarb infusion. His oxygen saturation continued to drop and he was profoundly hypotensive. After discussion with the patient's wife and children, the decision was made to pursue comfort care. Pressor support was decreased and the patient expired shortly after at 10:30AM on 9/17.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID positive
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Pt is 77 yo male s/p Pfizer COVID-19 vaccination: dose 1 on 1/28 and dose 2 on 2/18. Past medical history significant for HTN, T2DM who presented with fever and SOB with recent COVID19 diagnosis. He was treated with remdesivir and dexamethasone and symptomatically improved prior to home. He completed 5 days of remdesivir and his O2 needs were improving, though he still required 2lpm NC O2 at rest and on exertion. He was set up for home o2 as he otherwise felt improved and eager to go home. He declined services. He will complete the total 10d of dexamethasone. He can stop isolation/quarantine after 9-12 ( 10d from initial + testing).
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Decreased appetite, Dyspnoea, Fatigue
Clinical narrative: Pt has a history of CAD, hypertension, and peripheral vascular disease, and complains of a 10-day history of cough, shortness of breath, fatigue, malaise and decreased appetite.  He tested COVID positive.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Malaise, SARS-CoV-2 test positive
Clinical narrative: Pt has a history of CAD, hypertension, and peripheral vascular disease, and complains of a 10-day history of cough, shortness of breath, fatigue, malaise and decreased appetite.  He tested COVID positive.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine error - Vaccine was administered past its beyond use date. The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, COVID-19, Chest X-ray abnormal, Cough, Fatigue
Clinical narrative: Pt is 90 yo female s/p Pfizer COVID-19 vaccination: dose 1 on 1/23 and dose 2 on 2/13. PMH significant for heart failure, atrial fibrillation. Pt presented with 9/7/21 with 6 days of progressive fatigue and cough. CXR on admission with RLL infiltrate, and patient tested positive for COVID19. She was started on remdesivir, dexamethasone, and supplemental O2. Symptoms slowly improved and O2 was weaned to 1-2L prior to DC. She completed 10 day course of remdesivir/dexamethasone while inpt. She was noted to have UTI which was treated with ciprofloxacin to finish 10 day course ending 9/23/21. Given COVID19's clotting risk, patient discharged on low dose eliquis as well for 1 month.
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lung infiltration, SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: Pt is 90 yo female s/p Pfizer COVID-19 vaccination: dose 1 on 1/23 and dose 2 on 2/13. PMH significant for heart failure, atrial fibrillation. Pt presented with 9/7/21 with 6 days of progressive fatigue and cough. CXR on admission with RLL infiltrate, and patient tested positive for COVID19. She was started on remdesivir, dexamethasone, and supplemental O2. Symptoms slowly improved and O2 was weaned to 1-2L prior to DC. She completed 10 day course of remdesivir/dexamethasone while inpt. She was noted to have UTI which was treated with ciprofloxacin to finish 10 day course ending 9/23/21. Given COVID19's clotting risk, patient discharged on low dose eliquis as well for 1 month.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested Positive for Covid
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID positive
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Headache, Myalgia, Oxygen saturation decreased, Pyrexia
Clinical narrative: 58 yo female s/p Pfizer COVID19 vaccination: dose 1 on 3/2 and dose 2 on 3/23. PMH of alpha-1 antitrypsin deficiency s/p bilateral lung transplant on mycophenolate, tacrolimus, and prednisone 5 mg daily, atrial fibrillation, HTN, HLD, and recent diagnosis of COVID-19 infection on 9/8 who presents to the ED for evaluation of ongoing fever. She received monoclonal AB infusion on 9/9 prior to admission, but had ongoing fevers, myalgias and headache. ID recommended initiation of Remdesivir. She desaturated with exertion and was also started on Decadron. She completed 4 days of Remdesivir prior to discharge. She was doing well without hypoxemia, fevers or myalgias, therefore, discharged prior to completion of... the fifth dose of Remdesivir. She was discharged to home on 9/14 in stable conditions.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: 58 yo female s/p Pfizer COVID19 vaccination: dose 1 on 3/2 and dose 2 on 3/23. PMH of alpha-1 antitrypsin deficiency s/p bilateral lung transplant on mycophenolate, tacrolimus, and prednisone 5 mg daily, atrial fibrillation, HTN, HLD, and recent diagnosis of COVID-19 infection on 9/8 who presents to the ED for evaluation of ongoing fever. She received monoclonal AB infusion on 9/9 prior to admission, but had ongoing fevers, myalgias and headache. ID recommended initiation of Remdesivir. She desaturated with exertion and was also started on Decadron. She completed 4 days of Remdesivir prior to discharge. She was doing well without hypoxemia, fevers or myalgias, therefore, discharged prior to completion of... the fifth dose of Remdesivir. She was discharged to home on 9/14 in stable conditions.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine error - Vaccine was administered past its beyond use date. The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Enlarged uvula, Erythema, Hypertension, Hypoaesthesia oral, Lip swelling
Clinical narrative: On arrival to facility I   pre medicated with 1000mg tylenol and 10 mg allegra. I was given the Pfizer-BioNTech covid 19 Vaccine EUA in my left arm.   Within about 5 minutes of injection I noticed bilateral arm redness an itching.  The PA observed.  I then proceeded to note numbness and tingling to inside of mouth, lips and tongue.  The staff nurse came in to assess me, epi at bedside ready.  I then started to develop  a area of swelling across the bottom of my lower lip and note thickness sensation to tongue and uvula. RN notified the on staff physician who came in and assessed me.  The redness on arms was improving but other symptoms remained unchanged.  On staff doctor recommended that I go be assessed in ER.  I called for a ride to ER and was brought in to department and given 60 mg steroid orally.  My initial VS were abnormally high 170/109 bp.  I was then observed until improved symptoms.  Upon leaving ER I had mild generalized itching, small swelling to lower lip and small amount of tingling to tongue and lip.  I was instructed to take Benadryl 50 MG once home and pick up prescription for additional steroids and epi pen.  I have continued to use the steroids as instructed.  I notice that the numbness to tip of tongue and is still there prior to scheduled dose of steroids.  I have not had to use the epi pen
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral, Pruritus, Tongue disorder
Clinical narrative: On arrival to facility I   pre medicated with 1000mg tylenol and 10 mg allegra. I was given the Pfizer-BioNTech covid 19 Vaccine EUA in my left arm.   Within about 5 minutes of injection I noticed bilateral arm redness an itching.  The PA observed.  I then proceeded to note numbness and tingling to inside of mouth, lips and tongue.  The staff nurse came in to assess me, epi at bedside ready.  I then started to develop  a area of swelling across the bottom of my lower lip and note thickness sensation to tongue and uvula. RN notified the on staff physician who came in and assessed me.  The redness on arms was improving but other symptoms remained unchanged.  On staff doctor recommended that I go be assessed in ER.  I called for a ride to ER and was brought in to department and given 60 mg steroid orally.  My initial VS were abnormally high 170/109 bp.  I was then observed until improved symptoms.  Upon leaving ER I had mild generalized itching, small swelling to lower lip and small amount of tingling to tongue and lip.  I was instructed to take Benadryl 50 MG once home and pick up prescription for additional steroids and epi pen.  I have continued to use the steroids as instructed.  I notice that the numbness to tip of tongue and is still there prior to scheduled dose of steroids.  I have not had to use the epi pen
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Patient c\o generalized itching and received Benadryl po with good effect. Symptoms resolved prior to discharge.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse events or outcome, just that the vaccine was administered after the 30 days of received by our clinic.
Age: 67.0
Sex: F
Vaccine: UNK
Symptoms: Arthralgia, Condition aggravated, Joint range of motion decreased, Magnetic resonance imaging abnormal, Magnetic resonance imaging joint
Clinical narrative: after flu shot in Oct 2020 and 2 covid shots in Mar/Apr 2021, I developed frozen shoulder.  The pain has been progressively getting worse, went to my doctor, he ordered MRI and it confirmed the frozen shoulder.  This Friday I go for fluroscopic steroid injection  and then start physical therapy in Nov.  Extremely painful and limiting, and is especially bad at night.  Only relief I currently get is in the bathtub
Age: 67.0
Sex: F
Vaccine: UNK
Symptoms: Periarthritis, X-ray limb
Clinical narrative: after flu shot in Oct 2020 and 2 covid shots in Mar/Apr 2021, I developed frozen shoulder.  The pain has been progressively getting worse, went to my doctor, he ordered MRI and it confirmed the frozen shoulder.  This Friday I go for fluroscopic steroid injection  and then start physical therapy in Nov.  Extremely painful and limiting, and is especially bad at night.  Only relief I currently get is in the bathtub
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Aphasia, Computerised tomogram thorax, Magnetic resonance imaging head, Metastases to central nervous system, Surgery
Clinical narrative: Brain Metastasis. Lost ability to pick the right words. Surgery on 7/28/2021. Hospitalized for 1 week.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine error - Vaccine was administered past its beyond use date. The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Cystitis, Heavy menstrual bleeding, Menstrual disorder, Urine analysis abnormal
Clinical narrative: My menstrual cycle was affected.  My period was extremely heavy for 3 extra days with excessive bleeding,.  This has never happened.  Then I got a bladder infection which was documented by my primary physician.  Waiting to see what it does to my next cycle.
Age: 66.0
Sex: M
Vaccine: HEPAB
Symptoms: Diarrhoea, Fatigue, Myalgia
Clinical narrative: Patient receive 1st dose of Twinrix and experiences fatigue, muscle aches, and diarrhea more than 30mins after receiving vaccine. Patient stated SE was tolerable and did not report until came in for the second dose. patient was monitored for 15 mins after both doses to which he had no reactions. Advise patient to call immediate after onset of SX occurs with second dose.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Appendicitis, Ultrasound abdomen abnormal
Clinical narrative: Patient presented with abdominal pain that started after receiving his COVID vaccine and was found to have acute appendicitis
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Diarrhoea, Dizziness, Gastroenteritis viral
Clinical narrative: 09/21/2021- mid morning light headiness, chills, parched lips, nausea, stomach cramps, loose stool, full feeling 09/24/2021- severe stiffness in my joints
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Joint stiffness, Lip dry, Nausea, Physical examination
Clinical narrative: 09/21/2021- mid morning light headiness, chills, parched lips, nausea, stomach cramps, loose stool, full feeling 09/24/2021- severe stiffness in my joints
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine error - Vaccine was administered past its beyond use date. The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Balance disorder, Dizziness, Dyspnoea, Gait disturbance
Clinical narrative: He got his vaccine, just had a small soreness but exercised his arm.  He didn't have any other reaction at first.  Then about 2 days later he got up and went into the bathroom and seemed to be OK, and when he came back and sat on the bed he was dizzy.  They talked to his PCP she said that you can have a certain type of stroke that affects his balance and tested him for that, and did not determine that he had a stroke.  He went to a specialist and said that they felt that it was due to crystals in his ear, and then they said that he has not.  Then determined that the dizziness was no longer due to that or that he had an infection in his inner ear.  The thing is that he is still dizzy and is trying to work on a house, and has been on ladders and she's afraid for him to fall.   He does not have the energy that he has had in the past since getting the vaccine.  He has had cancer but his numbers are not high enough, and gets short of breath going up one flight of stairs, but cannot find anything wrong with his lungs or anything.  The latest thing on the balance, saw a specialist, Orthopedic surgery hospital that athletes go to.  The clinic sent him there to hearing and balance dept, and they gave him the treatment for the crystals as the clinic Dr. said they did not feel it was due to that.  Has had several treatments for the crystals, and that they are in place and that he should not be dizzy.   They are now trying to get the clinic approval to check out his feet.    He works every day at 84 years old doing renovation to a rental home they have.   It is really difficult for him to walk right now and are trying some other shot this Friday.  Going to have a procedure on Friday to help with his back issues.    He has balance issues and he blames it on the vaccine itself.   His wife feels that his tiredness is due to not sleeping well at night, only gets about 5 hours a night.   He is a light sleeper and wakes up for all things, and has restless leg syndrome.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Restless legs syndrome
Clinical narrative: He got his vaccine, just had a small soreness but exercised his arm.  He didn't have any other reaction at first.  Then about 2 days later he got up and went into the bathroom and seemed to be OK, and when he came back and sat on the bed he was dizzy.  They talked to his PCP she said that you can have a certain type of stroke that affects his balance and tested him for that, and did not determine that he had a stroke.  He went to a specialist and said that they felt that it was due to crystals in his ear, and then they said that he has not.  Then determined that the dizziness was no longer due to that or that he had an infection in his inner ear.  The thing is that he is still dizzy and is trying to work on a house, and has been on ladders and she's afraid for him to fall.   He does not have the energy that he has had in the past since getting the vaccine.  He has had cancer but his numbers are not high enough, and gets short of breath going up one flight of stairs, but cannot find anything wrong with his lungs or anything.  The latest thing on the balance, saw a specialist, Orthopedic surgery hospital that athletes go to.  The clinic sent him there to hearing and balance dept, and they gave him the treatment for the crystals as the clinic Dr. said they did not feel it was due to that.  Has had several treatments for the crystals, and that they are in place and that he should not be dizzy.   They are now trying to get the clinic approval to check out his feet.    He works every day at 84 years old doing renovation to a rental home they have.   It is really difficult for him to walk right now and are trying some other shot this Friday.  Going to have a procedure on Friday to help with his back issues.    He has balance issues and he blames it on the vaccine itself.   His wife feels that his tiredness is due to not sleeping well at night, only gets about 5 hours a night.   He is a light sleeper and wakes up for all things, and has restless leg syndrome.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy, Condition aggravated, Connective tissue disorder, Hysterectomy, Impaired work ability
Clinical narrative: As early of May, I had post menopausal bleeding. I also had a low grade fever not more than a week. I had in September a complete hysterectomy. I called the gynecologist and I was having a lot of bleeding and he brought me in, he did a DNC, lab work and biopsy and referred me to an oncologist. My adipose tissue generates fat and that is way I got cancer. They told me that I had stage 1 cancer and I am still recovering and I have not been back to work.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Neoplasm malignant, Postmenopausal haemorrhage, Pyrexia, Uterine cervix dilation procedure
Clinical narrative: As early of May, I had post menopausal bleeding. I also had a low grade fever not more than a week. I had in September a complete hysterectomy. I called the gynecologist and I was having a lot of bleeding and he brought me in, he did a DNC, lab work and biopsy and referred me to an oncologist. My adipose tissue generates fat and that is way I got cancer. They told me that I had stage 1 cancer and I am still recovering and I have not been back to work.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine error - Vaccine was administered past its beyond use date. The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse events or outcome, just that the vaccine was administered after the 30 days of received by our clinic.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Covid-Arm
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest X-ray normal, Diarrhoea, Exposure to SARS-CoV-2, Fatigue
Clinical narrative: Patient was admitted to Hospital on 4/30/21 with fatigue and diarrhea after covid exposure. Patient is fully vaccinated.  Patient was treated for covid and was discharged on 5/6/21.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient was admitted to Hospital on 4/30/21 with fatigue and diarrhea after covid exposure. Patient is fully vaccinated.  Patient was treated for covid and was discharged on 5/6/21.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood gases, Death, Endotracheal intubation, Fibrin D dimer, Intensive care
Clinical narrative: Admitted to COVID unit on 9/23. Was transferred to ICU and intubated on 10/2. Expired on 10/4
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse events or outcome, just that the vaccine was administered after the 30 days of received by our clinic.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine error - Vaccine was administered past its beyond use date. The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Extreme fatigue
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Mobility decreased, Pyrexia
Clinical narrative: I experienced weakness, fever, had trouble moving my legs
Age: 36.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Tenderness, X-ray normal
Clinical narrative: Week after receiving Johnson & Johnson vaccine in left shoulder, patient overnight developed first left shoulder pain (resolved), followed by left ulnar wrist pain. Tender left wrist without other significant findings. X-rays negative.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Colitis, Colonoscopy, Computerised tomogram, Pelvic pain
Clinical narrative: Approximately in the summer around 07/07/2021, I began having pain on the left side of my pelvis. I assumed at the time,  it was my ovarian region.  It has been monthly recurring and is ongoing.  07/07/2021 I went to see my doctor, I was told to get a CT scan. At the time they diagnosed it as colitis. It's been ongoing since.  The event repeated the following month.  The doctor had me get a colonoscopy- 08/26/2021.  No, I have not recovered from the AEs. I am still pursuing treatment because the issue is still repeating monthly.  I am not necessary stating that this is a result of receiving the vaccine. If it is helping research,  I am a proponent of the vaccine and I am happy to help.
Age: 50.0
Sex: F
Vaccine: UNK
Symptoms: Flushing, Injection site discolouration, Injection site pain, Injection site swelling, Periorbital swelling
Clinical narrative: Swollen and pale arm of injection (and pain in same arm).  flushing on face and neck and hives on neck.  Puffy eyes and face. Feeling like something is stuck in my throat.
Age: 50.0
Sex: F
Vaccine: UNK
Symptoms: Throat irritation, Urticaria
Clinical narrative: Swollen and pale arm of injection (and pain in same arm).  flushing on face and neck and hives on neck.  Puffy eyes and face. Feeling like something is stuck in my throat.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested Positive for Covid
Age: 27.0
Sex: F
Vaccine: HPV9
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Injection site redness, swelling, soreness.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Cardiac function test, Chest X-ray, Dizziness, Electrocardiogram
Clinical narrative: Dizzyness, weakness
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Full blood count, Metabolic function test, SARS-CoV-2 test
Clinical narrative: Dizzyness, weakness
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Adenovirus test, Angiogram pulmonary abnormal, Anticoagulant therapy, Aortic arteriosclerosis, Arteriogram coronary abnormal
Clinical narrative: ED to Hosp-Admission Discharged   9/19/2021 - 9/21/2021 (2 days)  Last attending ? Treatment team COVID-19  Presenting Problem/History of Present Illness/Reason for Admission Hypoxia [R09.02] Pulmonary embolism associated with COVID-19 (CMS/HCC) [U07.1, I26.99] COVID-19 [U07.1] Chronic combined diastolic and systolic heart failure     Hospital Course   77-year-old male admitted to the hospital with findings of acute pulmonary embolism in the setting of COVID-19 without significant pneumonia.  Was found to have respiratory insufficiency with hypoxia acute present on admission.  Was started on heparin infusion as well as remdesivir, monitored overnight with some improvement.  This morning upon evaluating him he appeared stable for discharge home.  He was taken off of heparin, converted to Eliquis which she will continue for 3 months.  We will stop acute interventions for COVID-19 given that he does not show signs of viral pneumonia.  Hypoxia is likely related to VTE.  He was instructed to isolate until October 3.  He will follow-up with PCP within 7 to 10 days.  Supplemental oxygen was provided at discharge as patient did qualify.  If there are complications regarding cost and affordability of Eliquis it would be recommended that patient's physician bridge him with Eliquis to Coumadin over the next month.  I stopped his Plavix, he should not be on triple therapy at this time, he will be on Eliquis, and aspirin and after 3 months if taken off of Eliquis could be then put back on Plavix. ED to Hosp-Admission Current   10/1/2021 - present (3 days)hospital    Last attending ? Treatment team Ventricular tachycardia (CMS/HCC)  Chief Complaint Patient presents with ? Irregular Heart Beat     1. Ischemic cardiomyopathy status post BiV ICD, now with recurrent V. tach.  Admit to general medical floor.  Monitor on telemetry.  Patient to be admitted for initiation of sotalol therapy, cardiology to follow.  Monitor QTC per protocol.  Check TSH.   2. Elevated troponins.  Likely due to demand ischemia in the setting of V. tach.  Trend troponins to peak, check 2D echocardiogram.  2D echocardiogram from September 7, 2021 shows reduced EF 40 to 45%, grade 2 diastolic dysfunction.  Await cardiology recommendations. 3. Subacute PE.  Patient on Eliquis therapy, continue for now. Check D-dimer to evaluate for worsening PE, given that he is now having recurrent V. tach episodes. 4. Type 2 diabetes.  Hold oral hypoglycemics.  Will place on insulin sliding scale Accu-Cheks per protocol. 5. CAD status post PCI.  Continue aspirin, statin, beta-blocker 6. COVID-19 infection.  Patient is tolerating room air, monitor clinically.  Continue supportive care with as needed albuterol inhaler, Mucinex.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Arteriosclerosis, Arteriosclerosis coronary artery, Bordetella test negative, COVID-19, Cardiac telemetry
Clinical narrative: ED to Hosp-Admission Discharged   9/19/2021 - 9/21/2021 (2 days)  Last attending ? Treatment team COVID-19  Presenting Problem/History of Present Illness/Reason for Admission Hypoxia [R09.02] Pulmonary embolism associated with COVID-19 (CMS/HCC) [U07.1, I26.99] COVID-19 [U07.1] Chronic combined diastolic and systolic heart failure     Hospital Course   77-year-old male admitted to the hospital with findings of acute pulmonary embolism in the setting of COVID-19 without significant pneumonia.  Was found to have respiratory insufficiency with hypoxia acute present on admission.  Was started on heparin infusion as well as remdesivir, monitored overnight with some improvement.  This morning upon evaluating him he appeared stable for discharge home.  He was taken off of heparin, converted to Eliquis which she will continue for 3 months.  We will stop acute interventions for COVID-19 given that he does not show signs of viral pneumonia.  Hypoxia is likely related to VTE.  He was instructed to isolate until October 3.  He will follow-up with PCP within 7 to 10 days.  Supplemental oxygen was provided at discharge as patient did qualify.  If there are complications regarding cost and affordability of Eliquis it would be recommended that patient's physician bridge him with Eliquis to Coumadin over the next month.  I stopped his Plavix, he should not be on triple therapy at this time, he will be on Eliquis, and aspirin and after 3 months if taken off of Eliquis could be then put back on Plavix. ED to Hosp-Admission Current   10/1/2021 - present (3 days)hospital    Last attending ? Treatment team Ventricular tachycardia (CMS/HCC)  Chief Complaint Patient presents with ? Irregular Heart Beat     1. Ischemic cardiomyopathy status post BiV ICD, now with recurrent V. tach.  Admit to general medical floor.  Monitor on telemetry.  Patient to be admitted for initiation of sotalol therapy, cardiology to follow.  Monitor QTC per protocol.  Check TSH.   2. Elevated troponins.  Likely due to demand ischemia in the setting of V. tach.  Trend troponins to peak, check 2D echocardiogram.  2D echocardiogram from September 7, 2021 shows reduced EF 40 to 45%, grade 2 diastolic dysfunction.  Await cardiology recommendations. 3. Subacute PE.  Patient on Eliquis therapy, continue for now. Check D-dimer to evaluate for worsening PE, given that he is now having recurrent V. tach episodes. 4. Type 2 diabetes.  Hold oral hypoglycemics.  Will place on insulin sliding scale Accu-Cheks per protocol. 5. CAD status post PCI.  Continue aspirin, statin, beta-blocker 6. COVID-19 infection.  Patient is tolerating room air, monitor clinically.  Continue supportive care with as needed albuterol inhaler, Mucinex.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Chlamydia test negative, Chronic left ventricular failure, Computerised tomogram, Condition aggravated
Clinical narrative: ED to Hosp-Admission Discharged   9/19/2021 - 9/21/2021 (2 days)  Last attending ? Treatment team COVID-19  Presenting Problem/History of Present Illness/Reason for Admission Hypoxia [R09.02] Pulmonary embolism associated with COVID-19 (CMS/HCC) [U07.1, I26.99] COVID-19 [U07.1] Chronic combined diastolic and systolic heart failure     Hospital Course   77-year-old male admitted to the hospital with findings of acute pulmonary embolism in the setting of COVID-19 without significant pneumonia.  Was found to have respiratory insufficiency with hypoxia acute present on admission.  Was started on heparin infusion as well as remdesivir, monitored overnight with some improvement.  This morning upon evaluating him he appeared stable for discharge home.  He was taken off of heparin, converted to Eliquis which she will continue for 3 months.  We will stop acute interventions for COVID-19 given that he does not show signs of viral pneumonia.  Hypoxia is likely related to VTE.  He was instructed to isolate until October 3.  He will follow-up with PCP within 7 to 10 days.  Supplemental oxygen was provided at discharge as patient did qualify.  If there are complications regarding cost and affordability of Eliquis it would be recommended that patient's physician bridge him with Eliquis to Coumadin over the next month.  I stopped his Plavix, he should not be on triple therapy at this time, he will be on Eliquis, and aspirin and after 3 months if taken off of Eliquis could be then put back on Plavix. ED to Hosp-Admission Current   10/1/2021 - present (3 days)hospital    Last attending ? Treatment team Ventricular tachycardia (CMS/HCC)  Chief Complaint Patient presents with ? Irregular Heart Beat     1. Ischemic cardiomyopathy status post BiV ICD, now with recurrent V. tach.  Admit to general medical floor.  Monitor on telemetry.  Patient to be admitted for initiation of sotalol therapy, cardiology to follow.  Monitor QTC per protocol.  Check TSH.   2. Elevated troponins.  Likely due to demand ischemia in the setting of V. tach.  Trend troponins to peak, check 2D echocardiogram.  2D echocardiogram from September 7, 2021 shows reduced EF 40 to 45%, grade 2 diastolic dysfunction.  Await cardiology recommendations. 3. Subacute PE.  Patient on Eliquis therapy, continue for now. Check D-dimer to evaluate for worsening PE, given that he is now having recurrent V. tach episodes. 4. Type 2 diabetes.  Hold oral hypoglycemics.  Will place on insulin sliding scale Accu-Cheks per protocol. 5. CAD status post PCI.  Continue aspirin, statin, beta-blocker 6. COVID-19 infection.  Patient is tolerating room air, monitor clinically.  Continue supportive care with as needed albuterol inhaler, Mucinex.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Coronavirus test negative, Cough, Diastolic dysfunction, Dyspnoea, Echocardiogram abnormal
Clinical narrative: ED to Hosp-Admission Discharged   9/19/2021 - 9/21/2021 (2 days)  Last attending ? Treatment team COVID-19  Presenting Problem/History of Present Illness/Reason for Admission Hypoxia [R09.02] Pulmonary embolism associated with COVID-19 (CMS/HCC) [U07.1, I26.99] COVID-19 [U07.1] Chronic combined diastolic and systolic heart failure     Hospital Course   77-year-old male admitted to the hospital with findings of acute pulmonary embolism in the setting of COVID-19 without significant pneumonia.  Was found to have respiratory insufficiency with hypoxia acute present on admission.  Was started on heparin infusion as well as remdesivir, monitored overnight with some improvement.  This morning upon evaluating him he appeared stable for discharge home.  He was taken off of heparin, converted to Eliquis which she will continue for 3 months.  We will stop acute interventions for COVID-19 given that he does not show signs of viral pneumonia.  Hypoxia is likely related to VTE.  He was instructed to isolate until October 3.  He will follow-up with PCP within 7 to 10 days.  Supplemental oxygen was provided at discharge as patient did qualify.  If there are complications regarding cost and affordability of Eliquis it would be recommended that patient's physician bridge him with Eliquis to Coumadin over the next month.  I stopped his Plavix, he should not be on triple therapy at this time, he will be on Eliquis, and aspirin and after 3 months if taken off of Eliquis could be then put back on Plavix. ED to Hosp-Admission Current   10/1/2021 - present (3 days)hospital    Last attending ? Treatment team Ventricular tachycardia (CMS/HCC)  Chief Complaint Patient presents with ? Irregular Heart Beat     1. Ischemic cardiomyopathy status post BiV ICD, now with recurrent V. tach.  Admit to general medical floor.  Monitor on telemetry.  Patient to be admitted for initiation of sotalol therapy, cardiology to follow.  Monitor QTC per protocol.  Check TSH.   2. Elevated troponins.  Likely due to demand ischemia in the setting of V. tach.  Trend troponins to peak, check 2D echocardiogram.  2D echocardiogram from September 7, 2021 shows reduced EF 40 to 45%, grade 2 diastolic dysfunction.  Await cardiology recommendations. 3. Subacute PE.  Patient on Eliquis therapy, continue for now. Check D-dimer to evaluate for worsening PE, given that he is now having recurrent V. tach episodes. 4. Type 2 diabetes.  Hold oral hypoglycemics.  Will place on insulin sliding scale Accu-Cheks per protocol. 5. CAD status post PCI.  Continue aspirin, statin, beta-blocker 6. COVID-19 infection.  Patient is tolerating room air, monitor clinically.  Continue supportive care with as needed albuterol inhaler, Mucinex.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Ejection fraction decreased, Embolism arterial, Emphysema, Enterovirus test negative, Heart rate irregular
Clinical narrative: ED to Hosp-Admission Discharged   9/19/2021 - 9/21/2021 (2 days)  Last attending ? Treatment team COVID-19  Presenting Problem/History of Present Illness/Reason for Admission Hypoxia [R09.02] Pulmonary embolism associated with COVID-19 (CMS/HCC) [U07.1, I26.99] COVID-19 [U07.1] Chronic combined diastolic and systolic heart failure     Hospital Course   77-year-old male admitted to the hospital with findings of acute pulmonary embolism in the setting of COVID-19 without significant pneumonia.  Was found to have respiratory insufficiency with hypoxia acute present on admission.  Was started on heparin infusion as well as remdesivir, monitored overnight with some improvement.  This morning upon evaluating him he appeared stable for discharge home.  He was taken off of heparin, converted to Eliquis which she will continue for 3 months.  We will stop acute interventions for COVID-19 given that he does not show signs of viral pneumonia.  Hypoxia is likely related to VTE.  He was instructed to isolate until October 3.  He will follow-up with PCP within 7 to 10 days.  Supplemental oxygen was provided at discharge as patient did qualify.  If there are complications regarding cost and affordability of Eliquis it would be recommended that patient's physician bridge him with Eliquis to Coumadin over the next month.  I stopped his Plavix, he should not be on triple therapy at this time, he will be on Eliquis, and aspirin and after 3 months if taken off of Eliquis could be then put back on Plavix. ED to Hosp-Admission Current   10/1/2021 - present (3 days)hospital    Last attending ? Treatment team Ventricular tachycardia (CMS/HCC)  Chief Complaint Patient presents with ? Irregular Heart Beat     1. Ischemic cardiomyopathy status post BiV ICD, now with recurrent V. tach.  Admit to general medical floor.  Monitor on telemetry.  Patient to be admitted for initiation of sotalol therapy, cardiology to follow.  Monitor QTC per protocol.  Check TSH.   2. Elevated troponins.  Likely due to demand ischemia in the setting of V. tach.  Trend troponins to peak, check 2D echocardiogram.  2D echocardiogram from September 7, 2021 shows reduced EF 40 to 45%, grade 2 diastolic dysfunction.  Await cardiology recommendations. 3. Subacute PE.  Patient on Eliquis therapy, continue for now. Check D-dimer to evaluate for worsening PE, given that he is now having recurrent V. tach episodes. 4. Type 2 diabetes.  Hold oral hypoglycemics.  Will place on insulin sliding scale Accu-Cheks per protocol. 5. CAD status post PCI.  Continue aspirin, statin, beta-blocker 6. COVID-19 infection.  Patient is tolerating room air, monitor clinically.  Continue supportive care with as needed albuterol inhaler, Mucinex.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Hiatus hernia, Hilar lymphadenopathy, Human metapneumovirus test, Human rhinovirus test, Hypoxia
Clinical narrative: ED to Hosp-Admission Discharged   9/19/2021 - 9/21/2021 (2 days)  Last attending ? Treatment team COVID-19  Presenting Problem/History of Present Illness/Reason for Admission Hypoxia [R09.02] Pulmonary embolism associated with COVID-19 (CMS/HCC) [U07.1, I26.99] COVID-19 [U07.1] Chronic combined diastolic and systolic heart failure     Hospital Course   77-year-old male admitted to the hospital with findings of acute pulmonary embolism in the setting of COVID-19 without significant pneumonia.  Was found to have respiratory insufficiency with hypoxia acute present on admission.  Was started on heparin infusion as well as remdesivir, monitored overnight with some improvement.  This morning upon evaluating him he appeared stable for discharge home.  He was taken off of heparin, converted to Eliquis which she will continue for 3 months.  We will stop acute interventions for COVID-19 given that he does not show signs of viral pneumonia.  Hypoxia is likely related to VTE.  He was instructed to isolate until October 3.  He will follow-up with PCP within 7 to 10 days.  Supplemental oxygen was provided at discharge as patient did qualify.  If there are complications regarding cost and affordability of Eliquis it would be recommended that patient's physician bridge him with Eliquis to Coumadin over the next month.  I stopped his Plavix, he should not be on triple therapy at this time, he will be on Eliquis, and aspirin and after 3 months if taken off of Eliquis could be then put back on Plavix. ED to Hosp-Admission Current   10/1/2021 - present (3 days)hospital    Last attending ? Treatment team Ventricular tachycardia (CMS/HCC)  Chief Complaint Patient presents with ? Irregular Heart Beat     1. Ischemic cardiomyopathy status post BiV ICD, now with recurrent V. tach.  Admit to general medical floor.  Monitor on telemetry.  Patient to be admitted for initiation of sotalol therapy, cardiology to follow.  Monitor QTC per protocol.  Check TSH.   2. Elevated troponins.  Likely due to demand ischemia in the setting of V. tach.  Trend troponins to peak, check 2D echocardiogram.  2D echocardiogram from September 7, 2021 shows reduced EF 40 to 45%, grade 2 diastolic dysfunction.  Await cardiology recommendations. 3. Subacute PE.  Patient on Eliquis therapy, continue for now. Check D-dimer to evaluate for worsening PE, given that he is now having recurrent V. tach episodes. 4. Type 2 diabetes.  Hold oral hypoglycemics.  Will place on insulin sliding scale Accu-Cheks per protocol. 5. CAD status post PCI.  Continue aspirin, statin, beta-blocker 6. COVID-19 infection.  Patient is tolerating room air, monitor clinically.  Continue supportive care with as needed albuterol inhaler, Mucinex.